Bristol-Myers Squibb Company

BMY
$61.48 (- $1.52 - 2.41%)
Last updated: 2026-10-24 01:01 UTC
BMY Metrics
Exchange
🇺🇸 NYSE XNYS
New York Stock Exchange, Inc.United StatesAmerica/New_York
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS1101221083
CUSIP110122108
Market Price61.48
Dividend Yield 4.22%
Dividend Growth
1Y +2.03%
3Y +5.34%
5Y +6.72%
10Y +4.24%
Annual Dividend 2.51
Latest Payout ($)0.63
Latest Payout Date2026-08-03
Dividend FrequencyQuarterly
P/E Ratio14.05
EPS2.97
Market Cap$110.5B
Book Value9.11
Price to Book5.957
Beta-0.31
52w High68.1
52w Low42.52
Next Earnings Date2026-10-28

Bristol-Myers Squibb Company trades under ticker BMY on NYSE as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US1101221083, CUSIP 110122108. Also searched as Bristol-Myers Squibb.

Related researchBMY stock priceBMY share priceBMY dividend historyBMY dividend yieldBristol-Myers Squibb dividend historyBristol-Myers Squibb dividend yield110122108Bristol-Myers Squibb stockBristol-Myers Squibb share price
About the Company
Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for serious diseases. Bristol-Myers Squibb Company focuses on major therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and neuroscience, serving patients with complex and often chronic conditions. Its portfolio includes small-molecule drugs, biologics, and cell therapies, reflecting a broad approach to advanced treatment design and delivery. The company supports healthcare systems through research-driven products used in hospitals, specialty clinics, and outpatient care settings around the world. Bristol-Myers Squibb Company plays an important role in the pharmaceutical market by providing therapies aimed at difficult-to-treat illnesses and by maintaining a diversified pipeline and product mix across multiple disease categories.
Price History